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Abstract 
 
Background: Camellia oleifera Abel. belongs to the family Theaceae and genus Camellia. It is commonly cultivated 
in southern China.  The seeds of C. oleifera have been reported to exhibit a diversity of pharmacological activities 
which include, but are not limited to, antioxidant, anti-cancer and antimicrobial. Pulmonary fibrosis is one of lethal 
causes of mortality across the globe and accretion of considerable amount of reactive oxygen species (ROS) in lungs 
have been implicated in the onset of this disease. Given the known antioxidant activity of C. oleifera seed extract 
(CSE), the present study was designed to evaluate the influence of CSE on the silica-induced pulmonary fibrosis rat 
models. 
Materials and Methods: Protective effect of CSE was determined in silica-induced pulmonary fibrosis rat models. 
Malondialdehyde (MDA), hydroxyproline (HP) and superoxide dismutase 2 (SOD-2) activity were determined by 
standard biochemical assays. Histopathological analysis was carried out by H and E staining. Phyto-constituents of 
CSE were identified by LC/MS analysis. 
Results: The results of this study indicated that CSE lowered the MDA and hydroxyproline content in silica-treated 
rats. Additionally, CSE also caused a significant increase in the expression of SOD-2 leading to scavenging of ROS. 
Hematoxylin and eosin (H and E) staining of lung tissue sections revealed that CSE maintained the integrity of 
parenchymatous cells of lungs and prevented the development of pulmonary fibrosis. To gain insights about the 
phytochemical constituents of CSE, LC/MS analysis was carried out and several antioxidant phenolics and flavonoids 
were tentatively identified.  
Conclusion: Taken together, we conclude that CSE prevents development of pulmonary fibrosis and the protective 
effect of CSE may be due to its ability to induce SOD-2 expression and due to the presence antioxidant phyto-
constituents. 
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Introduction 
 
Plants have been used as a source of medicine for the treatment of several diseases and disorders in different 
systems of medicine (Wei et al., 2012). Camellia oleifera Abel. belongs to family Theaceae and genus Camellia. It is 
commonly cultivated in southern China. The annual production of C. oleifera seed is around one million tons (Wei et 
al., 2012). These seeds are rich source of several secondery metabolites and have been reported to exhibit tremendous 
pharmaceutical potential. The C. oleifera saponins have been shown to have antioxidant activity, antihyperlipidemic, 
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antifungal, anticancer and several other activities (Yoshikawa et al., 2005; Kuo et al., 2010; Mu et al., 2013). Given 
the antioxidant activity C. oleifera, the present study was designed to evaluate the effect of C. oleifera seed extract on 
silica-induced pulmonary fibrosis. Pulmonary fibrosis has been reported to have caused considerable mortality either 
alone or in combination with tuberculosis (Bingham, 2011). Although several studies have been carried out on silica-
induced lung injury but the explicit molecular mechanism is still largely unknown. However, it has been reported that 
silica particles can incite the accretion of reactive oxygen species (ROS) and the discharge of hydrolytic enzymes  
which cause severe injuries to lungs (Murray and Nadel, 2000). Therefore, it is believed that drugs that exhibit 
antioxidant activities can prove useful for the treatment of silica-induced lung injury. Consistent with this, C. oleifera 
seeds have been reported to contain a number of antioxidant molecules and around 70 different saponins, several 
terpenoids, phenolics and flavonoids have been identified from it (Zhang et al., 2014). Therefore, in the current study 
the influence of C. oleifera seed extract (CSE) was for the first time evaluated in a rat model of pulmonary fibrosis 
developed by endotracheal silica. The changes in oxidative stress state was examined by estimating the plasma levels 
of malondialdehyde (MDA), and hydroxyproline (HP) as an index of collagen synthesis. Moreover, histopathological 
analysis was also carried to evaluate the influence of CSE on the anatomy of lung tissue. The results indicated that 
CSE extract exerts protective effect and improves upon the silica-induced lung injury and this protective effect was 
mainly found to be due to the capacity of CSE to prevent the accumulation of ROS. To identify, the active 
constuients, we carried out the LC/MS analysis of CSE and several constuients such as flavonoids and phenolics were 
identified.  
 
Materials and Methods 
Preparation of extract 
 
Dried seeds of C. oleifera were kindly provided by Xiaoliu Liu who obtained them from Medical School, Wuhan 
University of Science and Technology, Wuhan, Hubei, China. The authentic identification of the C. oleifera seeds 
was carried out by Xiaoliu Liu and submitted to herbarium in the department under accession number   HTMC112-
2016. The seeds were ground to a fine powder. Afterwards, 250 g of the powder was extracted with 500 ml of 70% 
ethanol and incubated at room temperature for 4 days. The extract (CSE) was then filtered and the solvent 
(ethanol/water) was removed using rotary evaporator under vacuum at 60 ᴼC. The dried extract (CSE) was stored at 4 
ᴼC for further experimentation.  
 
Animals 
 
Male Wistar albino rats (180–200 g) were purchased from were purchased from Shanghai Laboratory 
Animal Center of Chinese Academy of Sciences (Shanghai, China). Animals were kept in well ventilated rooms with 
controlled setting of light/dark cycle, temperature of 24 ± 2 and humidity of 40-60%. The study was approved by 
Medical ethics committee of Tongji Medical College of Huazhong University of Science and Technology under 
approval number METU-C9112A/17. 
 
Intratracheal instillation of silica 
 
Ketamine hydrochloride (i.p.; 50 mg/kg) was used to anesthetize the rats and instilled intratracheally (IT) 
with silica suspension (50 mg in 0.1ml saline/rat). The normal animals were adminstrated with an equal volume of 
sterilized saline only. After 90 days of silica injection, the rats were sacrificed and examined for pulmonary fibrosis. 
 
Animal grouping 
 
Animals were randomly divided into 5 groups of 10 mice per group: group I consisted of normal control 
mice that were administered with normal saline only, group II received a single IT instillation of silica, group III 
consisted of animals that received 100 mg/kg CSE   only.  Group IV and V received a single IT instillation of silica 
plus 50 mg/kg and 100 mg/kg CSE respectively. The day of IT injection of silica or saline was taken as day 0. 
 
Biochemical assays 
 
The MDA levels of the plasma were estimated by the methods as described previously (Buege and Aust, 
1978; Yagi, 1984). The obtained values were compared to a series of 1, 1, 3, 3-tetraethoxypropane standard solutions. 
To obtain the plasma samples, 1ml of blood was collected from left ventricle, and centrifuged for 5min at 1000g, and 
then diluted 20 times with phosphate buffer solution, pH of 7.4. The results were expressed in the units of mmol/L. 
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To determine the HP, left lobe of lung was used and the HP content was determined by a colorimetric protocol of 
Edwards and O’Brien (1980). The absorbance of the samples was taken at 500 nm and the HP content was expressed 
as mg/g tissue. 
 
 
Histopathological analysis 
 
For histopathological analysis, lungs were washed twice with PBS and fixed in 4% paraformaldehyde at 4 
°C for 24 h. Afterwards, lung tissues were embedded in paraffin and then sectioned. Subsequently, sectioned tissues 
were stained with hematoxylin and eosin (HE staining). Pathological changes, such as fibrosis, severity of lesion 
inflammatory cell infiltration and edema, were observed under Ti–S bright field microscope (Nikon, Melville, NY, 
USA) (Zhang et al., 2014) 
 
Western blot analysis 
 
Cells from the lung tissues of all the groups were harvested and lysis was done with lysis buffer. The 
proteins levels in the cell extracts were determined by BCA assay by specific antibodies. Equal concentrations of 
protein from each sample were loaded and run on denaturing SDS gel (12%).  Finally, the proteins were then 
electroblotted on polyvinylidene difluoride membranes. The β-actin was used as internal control. 
 
LC/MS analysis 
 
The chemical constituents of CSE were tentatively identified by LC–ESI-MS using LC–MS QqQ-6410B 
(Agilent Technologies) comprising of a chromatographic system connected to a spectrometer having an ESI source. 
The MS conditions were as; MS range 100–1000 Da, The mass spectra were attained in both positive and negative 
modes. The gas temperature was 325 ◦C, nebulizer gas 45 Psi and capillary voltage was kept at 4000 V. HPLC 
analysis was done using chromolith RP-18e column (4.6 mm ID, 50 mm length). The temperature of the column was 
kept at 30 ◦C. The mobile phase was water and 0.1% FA and acetonitrile. The gradient elution programe was; 0–10 
min, 10–50% B; 10–15 min, 50% B; 15–17 min, 50–100% B and 17–19 min, 100%. The flow rate was kept at 0.5 
ml/min and the injection volume was 2.5 μl. 
 
Statistical analysis 
 
All experiments were carried out in triplicates and expressed as mean ± SD.  Statistical analysis was carried 
out by one-way ANOVA using GraphPad 7. Significant values were tested with Tukey’s test. *p<0.01 and **p<0.001 
were taken as an indication of a statistically significant difference. 
 
Results 
CSE prevents lipid peroxidation  
 
MDA is a marker of oxidative stress and is the product of lipid peroxidation. We determined the MDA levels 
in lung tissues of all the groups on the 90th day and the results are summarized in Figure 1. The results indicated that 
the MDA levels were significantly (#p<0.01) higher in silica-treated group (Group III) than the normal rats (Group I). 
No significant difference was observed between the normal rats (Group 1) and the rats adminstrated with 100 mg/kg 
of CSE (Group II) Moreover, it was observed that administration of CSE to the silica-treated rats groups (i.e. Group 
IV and Group V), showed significantly (*p<0.01 and **p<0.001) lower MDA levels as compared to the silica-treated 
group (Group III). Taken together these results indicate SCE scavenges ROS in lung silica-treated rats preventing 
lipid peroxidation and hence lower MDA content.  
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Figure 1: Effect of CSE on the MDA concentrations in Group I (normal rats), Group II (Rats receiving CSE 100 
mg/kg), Group III (rats receiving single IT silica), Group IV (rats receiving single IT silica plus 50 mg/kg of CSE) 
and Group V (rats receiving single IT silica plus 100 mg/kg of CSE). All experiments were carried out at least in 
triplicates. The differences between the Group I and Group III were significant at #p<0.01 and the differences 
between the Group III and Groups IV or V were significant at *p<0.01 and **p<0.001 respectively. 
 
CSE lessens the Hydroxyproline (HP) levels 
 
We also determined the collagen formation in the pulmonary tissue by estimating the concentration of the 
HP of the lungs on 90th day of treatment. The HP concentration of the lungs of each group is depicted in Figure 2. The 
results indicated a significant increase (#p<0.01) in HP concentrations of the lung in silica-treated group (Group III) in 
comparison to the control group (Group I). However, it was observed that 50 mg/kg (Group IV) and 100 mg/kg 
(Group V) of CSE administration lead to a slight but significant (*p<0.01) reduction of HP concentrations. 
 
Figure 2: Effect of CSE on the hydroxyproline (HP) concentrations in all rat groups. All experiments were carried 
out at least in triplicates. The differences between the Group I and Group III were significant at #p<0.01 and the 
differences between the Group III and Groups IV/V were significant at *p<0.01. 
 
CSE enhances expression of SOD-2 
 
Since CSE prevented lipid peroxidation, we speculated that it might induce the expression of antioxidant 
enzymes (Figure 3). Therefore we determined the expression of superoxide dismutase 2 (SOD-2) in all the treatment 
groups by western blotting. It was observed that CSE significantly (p<0.01) enhanced the protien expression of SOD-
2 in lungs of both CSE treated normal (Group II) as well as the silica-treated plus CSE (Group IV and V) rats.  
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Figure 3: Effect of CSE on the protien expression of SOD-2 (A) Western blots showing expression of SOD-2 (B) 
quantification of SOD-2 expression by densitometry. All experiments were carried out at least in triplicates. The 
differences between the Group I and Group II were significant at #p<0.01 and the differences between the Group III 
and Groups IV/V were significant at *p<0.01. 
 
Histopathological analysis 
 
To examine the influence of CSE on the silica-induced lung injuries, we carried out the histopathological 
analysis by light microscopy 90 days after treatment (Figure 4). The results indicated that lungs of rats in control 
group (Group I), which received IT saline only and normal rats receiving 100 mg/kg of CSE (Group II) exhibited 
normal lung structure and no lesions were observed. However, after 90 days of instillation of silica (Group III) caused 
perivascular and peribronchilal fibrosis together with silicotic nodules and dispersed hyalinized collagen (Figure 4).  
However, in groups which received single IT silica plus 50 mg/kg (Group IV) or 100 mg/Kg (Group V) of CSE- such 
events were less pronounced and the numbers of nodules were less (Figure 4). Indicating that administration of CSE 
confers protective effect to silica-treated rats 
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Figure 4: Photomicrographs of lung tissues of (A) Group I (normal rats) (B) Group II (Rats receiving CSE 100 
mg/kg), (C) Group III (rats receiving single IT silica), (C) Group IV (rats receiving single IT silica plus 50 mg/kg of 
CSE) and (D) Group V (rats receiving single IT silica plus 100 mg/kg of CSE). The photomicrographs are 
representatives of several replicates. 
 
Phytochemical analysis of CSE 
 
To gain insights about the phytochemical constituents of CSE, we carried out LC/MS analysis (Figure 5). 
The LC/MS analyses lead to the tentative identification of several phenolics and flavonoids. These include theogallin, 
gallic acid, Gallocatechin, epigallocatechin, caffeine, Quercetin 3-glucoside and Catechin gallate. These compounds 
were identified based on the mass and in the light of literature (Yao et al., 2004). 
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Figure 5: Phytochemical analysis of CSE by LC/MS. The peaks 1-7 represent theogallin, gallic acid, Gallocatechin, 
epigallocatechin, Caffeine, Quercetin 3-glucoside and Catechin gallate respectively. 
 
Discussion 
 
Pulmonary fibrosis is a recurrent reaction to a wide array of injuries lungs. Though several mechanisms that 
initiate pulmonary fibrosis have been proposed, oxidative stress involves rapid proliferation and significant buildup of 
connective tissue ultimately affecting normal parenchyma. The pathogenesis of pulmonary fibrosis comprises of 
injuries to endothelial and epithelial cells, in flow of inflammatory cells which generate chemicals that mediate the 
proliferation and stimulation of fibroblasts (Gorinstein et al., 1994; Uchida et al., 1995; Buege and Aust, 1978). 
Silica-induced pulmonary fibrosis is somewhat different from other types of pulmonary fibrosis, e.g. by bleomycin. 
Silica particles which are insoluble are accumulated in lung parenchyma is successively gulped by macrophages and 
additional injuries are results of internal reactions in these cells (Ahn et al., 2002). It has been reported that certain 
exogenous agents can initiate the development of pulmonary fibrosis through accretion of considerable amounts of 
ROS in animal models (Franklin et al., 1997). Moreover, there are concrete evidences that indicate accretion of ROS 
by dusts essentially or through the inflammatory response is one of the important routed for initiation of pulmonary 
fibrosis (Marshall et al., 1997; Kinnula et al., 2005; Caillet et al., 2006). Subsequently, the accumulation of significant  
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amounts of ROS cause lipid peroxidation of cellular membranes and inactivate the enzymes (Kelley, 1990). 
Consistent with this, antioxidants from natural products are considered important targets for prevention of pulmonary 
fibrosis. A number of studies have reported that plant extracts such as grape seed extract, have proved beneficial in 
the prevention of pulmonary fibrosis (Ahn et al., 2002; Donnelly et al., 2004; Lorenz et al., 2003). The present study 
was, therefore, carried out to evaluate the influence of Camellia oleifera seed extract on silica-induced lung injury. 
The results of microscopic and biochemical analysis revealed that treatment after silica instillation reduced and 
conferred protective effects against silica toxicity in rats. The CSE lead to significant reduction in the MDA 
concentrations of CSE-treated groups indicating that CSE prevented lipoid peroxidation. However, it should also be 
noted that CSE caused reduction in the hydroxyproline (HP) levels in silica-treated rats. To investigate the 
mechanism by which CSE confers protective effect against silica-induced lung injury, we determined the expression 
of superoxide dismutase 2 (SOD-2) in the lung tissues of all the rat groups. The results indicated that CSE enhanced 
the expression of SOD-2 in lungs of silica-treated rats. However, our study does not exclude the possibility of 
involvement of other antioxidant enzymes in CSE-conferred protective effects in silica-induced lung fibrosis. To gain 
insights about the constituents of CSE potentially responsible for the protective effect, we carried out the LC/MS 
analysis of CSE and several compounds including flavonoids and phenolics were identified.  These include 
theogallin, gallic acid, Gallocatechin, epigallocatechin, caffeine, Quercetin 3-glucoside and Catechin gallate. 
Taken together, we conclude that CSE has a protective effect and may prevent silica-induced lung injury and 
fibrosis. The protective effects are mainly due to the activation of antioxidant systems such as SOD-2 and the 
presence of several antioxidant constuients. 
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